glucosamine + chondroitin

Chondroprotectors. Symptomatic slow-acting drugs for osteoarthritis (SYSADOA)

ATC code: M01AX05 (Glucosamine)

Brand names – supplements

Cosamin DS, Move Free Advanced, Osteo Bi-Flex Triple Strength

Supplements are not tested in clinical trials and are not registered as medications.

Mechanism of action

Glucosamine is an amino monosaccharide, a precursor of glycosaminoglycans and proteoglycans in cartilage matrix. Chondroitin sulphate is the main glycosaminoglycan of articular cartilage. With oral intake, both are partially absorbed (glucosamine bioavailability 25%, chondroitin 13%) and undergo substantial hepatic and intestinal inactivation. Direct incorporation into cartilage matrix synthesis is not proven clinically. The presumed mechanism: anti-inflammatory effect on the synovial membrane and inhibition of IL-1β-induced metalloproteinase expression.

Indications

Knee osteoarthritis

Not recommended

Glucosamine and chondroitin are the most-studied and most-debated osteoarthritis nutraceuticals. The independent GAIT RCT (NEJM 2006, 1,583 patients, 6 months) showed no clinically meaningful effect on pain or function versus placebo in the general population. A subgroup with moderate-to-severe pain had a modest effect from the combination. 2019 strongly recommends AGAINST glucosamine and chondroitin in knee, hip, and hand osteoarthritis. 2019 gives mixed guidance – pharmaceutical glucosamine sulphate may be considered; over-the-counter glucosamine hydrochloride is not.

Practical notes

Timing and administration

Take with food to reduce dyspepsia. The effect (if any) develops over 2–3 months of continuous use. Courses of 3–6 months with possible repetition. Does not have significant drug interactions when combined with NSAIDs, paracetamol, or intra-articular injections.

Dose titration

Glucosamine 1,500 mg daily (split 500 mg three times daily or single 1,500 mg). Chondroitin 1,200 mg daily (split 400 mg three times daily). Combination products typically contain 500 mg glucosamine + 400 mg chondroitin per tablet – 3 tablets daily. Lower doses do not show clinical effects even in positive-result subgroups.

Monitoring

At 3 months, assess clinical effect – pain intensity (VAS), functional indices (WOMAC, KOOS). If no improvement, discontinue – do not repeat the course. In patients on warfarin, monitor INR – cases of increased anticoagulation with glucosamine are reported.

Food and drinks

Dietary sources of glucosamine and chondroitin: bone broths, shellfish cartilage, fish skin, gelatin. Food content is incomparably lower than therapeutic doses – one serving of homemade bone broth contains 100–300 mg of glucosamine versus a 1,500 mg treatment dose. Reaching the therapeutic dose through diet is practically impossible.

Common myths

Myth: “glucosamine and chondroitin restore cartilage”. Fact: direct incorporation into cartilage matrix synthesis is not proven. RCTs assess only clinical effects on pain and function, not structural changes. No conservative intervention “restores” cartilage structure.

Myth: “cheap supplements work the same as Dona”. Fact: the difference between pharmaceutical glucosamine sulphate and over-the-counter glucosamine hydrochloride is substantial. Positive RCTs mainly used the sulphate form at 1,500 mg daily. Hydrochloride in most supplements is a less-studied form with worse results.

Myth: “it doesn't work only because you don't take enough”. Fact: even at the correct dose and form, the effect is clinically minor in the general population. 2019 strongly recommends against. Money spent on chondroprotectors is better invested in physical rehabilitation and, when indicated, joint replacement.

Frequently asked

What is glucosamine + chondroitin used for?

glucosamine + chondroitin is evaluated for the following indications with varying evidence strength: Knee osteoarthritis (evidence tier D), Anti-aging, longevity, and quality-of-life enhancement in healthy adults (evidence tier F). See the full indication matrix with dosing and citations above on this page.

What are the side effects of glucosamine + chondroitin?

Common side effects of glucosamine + chondroitin (≥ 1 in 100): Nausea, epigastric discomfort, Diarrhoea or constipation, Heartburn. See the Safety section for uncommon and serious reactions.

Is glucosamine + chondroitin safe during pregnancy?

FDA category C. Pregnancy data are insufficient. Use in pregnancy and breastfeeding is not recommended without clinical indication.

Is glucosamine + chondroitin compatible with breastfeeding?

No data on transfer into breast milk. Use during breastfeeding is not recommended.

Who should not take glucosamine + chondroitin?

glucosamine + chondroitin is contraindicated in: Hypersensitivity to glucosamine or chondroitin; Severe shellfish allergy (glucosamine from crab and shrimp shells); Phenylketonuria (for specific effervescent forms); Severe renal or hepatic impairment. Full list in the Safety section.

“glucosamine and chondroitin restore cartilage”

direct incorporation into cartilage matrix synthesis is not proven. RCTs assess only clinical effects on pain and function, not structural changes. No conservative intervention “restores” cartilage structure.

“cheap supplements work the same as Dona”

the difference between pharmaceutical glucosamine sulphate and over-the-counter glucosamine hydrochloride is substantial. Positive RCTs mainly used the sulphate form at 1,500 mg daily. Hydrochloride in most supplements is a less-studied form with worse results.

“it doesn't work only because you don't take enough”

even at the correct dose and form, the effect is clinically minor in the general population. ACR 2019 strongly recommends against. Money spent on chondroprotectors is better invested in physical rehabilitation and, when indicated, joint replacement.

glucosamine + chondroitin

Mechanism of action

Indications

Knee osteoarthritis

Anti-aging, longevity, and quality-of-life enhancement in healthy adults

Practical notes

Timing and administration

Dose titration

Monitoring

Food and drinks

Common myths

Safety

Contraindications

Serious adverse effects

Common adverse effects

Uncommon adverse effects

PregnancyFDA C

Breastfeeding

Frequently asked